Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

China SXT Pharmaceuticals (SXTC) Other Gross PP&E Adjustments (2018 - 2025)

Historic Other Gross PP&E Adjustments for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q1 2025 value amounting to $2.2 million.

  • China SXT Pharmaceuticals' Other Gross PP&E Adjustments fell 111.84% to $2.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.2 million, marking a year-over-year decrease of 111.84%. This contributed to the annual value of $2.2 million for FY2025, which is 111.84% down from last year.
  • China SXT Pharmaceuticals' Other Gross PP&E Adjustments amounted to $2.2 million in Q1 2025, which was down 111.84% from $2.3 million recorded in Q1 2024.
  • In the past 5 years, China SXT Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $2.7 million during Q1 2022, and its lowest value of $1.9 million during Q1 2023.
  • Moreover, its 5-year median value for Other Gross PP&E Adjustments was $2.3 million (2024), whereas its average is $2.3 million.
  • In the last 5 years, China SXT Pharmaceuticals' Other Gross PP&E Adjustments plummeted by 2916.78% in 2023 and then surged by 1865.03% in 2024.
  • China SXT Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $2.5 million in 2021, then increased by 5.96% to $2.7 million in 2022, then dropped by 29.17% to $1.9 million in 2023, then increased by 18.65% to $2.3 million in 2024, then decreased by 1.12% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q1 2025, $2.3 million for Q1 2024, and $1.9 million during Q1 2023.